ATE437856T1 - 5-aminoindol-derivate - Google Patents

5-aminoindol-derivate

Info

Publication number
ATE437856T1
ATE437856T1 AT06706180T AT06706180T ATE437856T1 AT E437856 T1 ATE437856 T1 AT E437856T1 AT 06706180 T AT06706180 T AT 06706180T AT 06706180 T AT06706180 T AT 06706180T AT E437856 T1 ATE437856 T1 AT E437856T1
Authority
AT
Austria
Prior art keywords
aminoindole derivatives
aminoindole
derivatives
Prior art date
Application number
AT06706180T
Other languages
English (en)
Inventor
Matthias Heinrich Nettekoven
Jean-Marc Plancher
Olivier Roche
Rosa Maria Rodriguez-Sarmiento
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE437856T1 publication Critical patent/ATE437856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06706180T 2005-01-19 2006-01-10 5-aminoindol-derivate ATE437856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100312 2005-01-19
PCT/EP2006/000125 WO2006077024A2 (en) 2005-01-19 2006-01-10 5-aminoindole derivatives

Publications (1)

Publication Number Publication Date
ATE437856T1 true ATE437856T1 (de) 2009-08-15

Family

ID=36540146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06706180T ATE437856T1 (de) 2005-01-19 2006-01-10 5-aminoindol-derivate

Country Status (16)

Country Link
US (2) US7456174B2 (de)
EP (1) EP1841734B1 (de)
JP (1) JP2008527014A (de)
KR (1) KR100902707B1 (de)
CN (1) CN101107227B (de)
AR (1) AR053435A1 (de)
AT (1) ATE437856T1 (de)
AU (1) AU2006207712A1 (de)
BR (1) BRPI0606502A2 (de)
CA (1) CA2594487A1 (de)
DE (1) DE602006008104D1 (de)
ES (1) ES2327776T3 (de)
IL (1) IL184433A0 (de)
MX (1) MX2007008676A (de)
TW (1) TW200637817A (de)
WO (1) WO2006077024A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040096216A (ko) 2003-05-07 2004-11-16 삼성전자주식회사 제빵기
AR048134A1 (es) * 2003-12-15 2006-04-05 Lundbeck & Co As H La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
CN101326187A (zh) * 2005-12-15 2008-12-17 霍夫曼-拉罗奇有限公司 吡咯并[2,3-c]吡啶衍生物
US7834050B2 (en) 2006-03-29 2010-11-16 Duke University Small molecule insulin mimetics absent quinones
MX2008013196A (es) * 2006-04-12 2008-10-22 Hoffmann La Roche 5-amido-2-carboxiamida-indoles.
US7432255B2 (en) 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
US7514433B2 (en) * 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
TW200823204A (en) * 2006-10-17 2008-06-01 Arena Pharm Inc Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
US7648979B2 (en) * 2007-02-07 2010-01-19 Hoffmann-La Roche Inc. 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
KR20090127286A (ko) * 2007-03-01 2009-12-10 얀센 파마슈티카 엔.브이. 히스타민 ｈ３ 수용체 조절제로서의 인돌 및 벤조티오펜 화합물
WO2009013195A1 (en) * 2007-07-25 2009-01-29 F. Hoffmann-La Roche Ag Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
CN106905286B (zh) * 2015-12-23 2020-07-24 江苏恩华药业股份有限公司 一种黄酮类化合物衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705095B1 (fr) 1993-05-12 1995-06-23 Adir Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
SK6652000A3 (en) * 1997-11-11 2002-05-09 Pfizer Prod Inc Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
AU2001255202A1 (en) * 2000-03-31 2001-10-15 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands
ATE430730T1 (de) * 2000-03-31 2009-05-15 Ortho Mcneil Pharm Inc Phenyl-substituierte indole als h3 histaminrezeptorantagonisten
KR20030088508A (ko) * 2001-04-20 2003-11-19 와이어쓰 5-하이드록시트립타민-6 리간드로서의헤테로사이클릴옥시-, -티옥시- 및 -아미노벤즈아졸 유도체
MY135686A (en) * 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
CA2569611C (en) * 2004-06-21 2012-12-11 F. Hoffmann-La Roche Ag Indole derivatives as histamine receptor antagonists

Also Published As

Publication number Publication date
US20090069311A1 (en) 2009-03-12
CA2594487A1 (en) 2006-07-27
BRPI0606502A2 (pt) 2009-06-30
JP2008527014A (ja) 2008-07-24
US7456174B2 (en) 2008-11-25
AU2006207712A1 (en) 2006-07-27
DE602006008104D1 (de) 2009-09-10
KR20070098922A (ko) 2007-10-05
TW200637817A (en) 2006-11-01
WO2006077024A3 (en) 2006-09-08
ES2327776T3 (es) 2009-11-03
AR053435A1 (es) 2007-05-09
CN101107227A (zh) 2008-01-16
US20060160855A1 (en) 2006-07-20
EP1841734A2 (de) 2007-10-10
KR100902707B1 (ko) 2009-06-15
US7754736B2 (en) 2010-07-13
IL184433A0 (en) 2007-10-31
CN101107227B (zh) 2010-09-22
MX2007008676A (es) 2007-07-25
WO2006077024A2 (en) 2006-07-27
EP1841734B1 (de) 2009-07-29

Similar Documents

Publication Publication Date Title
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
HRP20150012T1 (xx) 39-dezmetoksi derivati rapamicina
DK2016080T3 (da) Dihydropyrazolopyrimidinon-derivater
ATE408603T1 (de) Pyrazolylcarboxanilide
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE501119T1 (de) Entzündungshemmende indol-derivate
ATE512135T1 (de) Spiroindolinonderivate
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
ATE383361T1 (de) Pyrrazolopyrimidinderivate
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
IL184433A0 (en) 5-aminoindole derivatives
ATE487691T1 (de) Acetylenderivate
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
EP1916896A4 (de) Nichtsteroid-antiandrogene
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK1740574T3 (da) 4-amino-5-cyanopyrimidinderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1841734

Country of ref document: EP